Test #19 (BMR Week 2N Block 2: Pulm) Flashcards
Test taken 5/14/2014 Test review 5/14/2014
Role of following in allergic asthma tx: (1) Histamine receptor antagonists (2) LTD4 (3) Other drug that is efficacious
(1) Histamine may contribute to pathogenesis of asthmatic bronchoconstriction but its role appears to be relatively minor given that histamine antagonists lack efficacy in allergic asthma (2) Although numerous substances play role in pathogenesis of allergic asthma, only leukotrienes (LTC4, D4, AND E4) and acetylcholine have pharmacologic receptor antagonists that offer clear therapeutic benefit
Major toxicities of theophylline
Seizures are major cause of morbidity and mortality from theophylline intoxication
Rifampin monotherapy used for
N. meningitidis exposure
(1) Dx: recurrent sinopulmonary and GI tract infections (2) Explain: blood transfusion with O negative packed red blood cells leads to diffuse itching, skin rash, bronchospasm, and death 30 min later
(1) Selective IgA defeciency (2) Assoc. w/ anaphylactic response to transfused blood products due to an immune response against transfused IgA which the patient’s body recognizes as foreign
Dx: Patient’s flow-volume loop curve shows decrease in all lung volumes and significantly decreased expiratory flow rates
COPD - either chronic bronchitis or emphysema
(1) Direct indicator of status of alveolar ventilation (2) Give examples/conditions of this
(1) Arterial paCO2 (2) Hypocapnia: ongoing alveolar hyperventilation (3) Hypercapnia: due to upper airway obstruction, reduced ventilatory drive, respiratory muscle fatigue, and/or decreased chest wall compliance
(1) Use of monotherapy isoniazid for Tb (2) Risk/Outcome otherwise
(1) Isoniazid monotherapy may be used for patients who have a positive PPD and a negative chest x-ray (ie, no evidence of clinical disease) (2) Active tuberculosis NEVER treated with drug monotherapy due to fast emergence of mycobacterial antibiotic resistance from rapid, selective gene mutaitons.
Mechanisms of following antifungals: (1) Amphotericin B (2) Itraconazole (3) Terbinafine (4) Griseofulvin (5) Caspofungin (6) Flucytosine
(1) Binds ergosterol in fungal membrane, leading to pore formation and cell lysis (2) Inhibits synthesis of ergosterol by fungal cytochrome P450 enzymes. Azoles also suppress human P450 system, resulting in may drug-drug interactions. (3) Inhibits fungal enzyme squalene-2,3-epoxidase, which ultimately results in decreased synthesis of ergosterol. Accumulates in skin and nails, so used to treat dermatophyses. (4) enters fungal cells and binds microtubules, inhibiting mitosis (5) (Echinocandin antifugals) Block glucan (1,3-beta-D glucan = major polysaccharide component of fungal cell wall) synthesis (6) Inhibits synthesis of both DNA (replication) and RNA (protein synthesis) in fungal cells. Mainly used as synergistic agent with amphotericin B. Drug combination particularly important in tx of crytococcal meningitis.
c Flow rate in pulmonary versus systemic circuits
Pulmonary circulation continuous circuit with systemic circulation. Rate of blood flow thru pulmonary circulation must equal the rate of blood flow in the systemic circulation at all times. Arterial pressures and oxygen contents of the pulmonary and systemic arterial systems considerably different both at rest and during exercise.
(1) Antituberculous agent most assoc. with decreased visual acuity (2) specific eye condition it causes & its presentation (3) Drug’s mechanism
(1) Ethambutol = most notorious for adverse visual changes (2) optic neuritis, which typically persents in conjuction with decreased visual acuity, central scotoma, and color blindness) (3) Inhibits carbohydrate polymerization, thereby preventing peptidoglycan wall synthesis
(1) Mechanism of Amphotericin toxicity (2) Amphotericin most important adverse effects
(1) In addition to binding ergosterol of fungal cell membranes to exert its antifungal effects, also binds cholesterol to some degree, causing toxicity in human tissues (2) Nephrotoxicity, Hypokalemia, and Hypomagnesemia
(1) 2 major risk factors for ARDS (2) Pathophysiology of ARDS
(1) Sepsis and shock 2 major risk factors for developing adult respiratory distress syndrome (ARDS, aka ‘shock lung’) (2) Produces non-cardiogenic pulmonary interstitial and intra-alveolar edema, inflammation, and alveolar hyaline membranes
Mechanism of mycobaterial resistance to isoniazid
Non-expression of catalase-peroxidase enzyme or through genetic modification of isoniazid binding site on mycolic acid synthesis enzyme. Note: Mechanism not fully understood. It is know that Isoniazid must be processed by mycobacterial catalase-peroxidase for drug to be activated within bacteria, and that isoniazid requires a specific protein sequence in its enzyme target (an enzyme necessary for mycolic acid synthesis).
Clinical use and mechanism of N-acetylcysteine
Mucolytic agent in tx of CF. Works by cleaving disulfide bonds within mucous glycoproteins, thus loosening thick sputum.
(1) pO2 in left atrium versus pulmonary capillaries (2) explain
(1) pO2 in left atrium is lower than that in pulmonary capillaries because (2) deoxygenated blood originating from bronchial arteries mixes with oxygenated blood in pulmonary veins